Opinion

Video

Insights from the COORDINATE-Diabetes Trial

Key Takeaways

  • The trial focused on improving cardiovascular risk management in type 2 diabetes through a coordinated care model.
  • Structured care pathways and multidisciplinary teams were key interventions to enhance guideline adherence.
SHOW MORE

A panel of experts explores the objectives and design of the COORDINATE-Diabetes trial, discussing its potential impact on the treatment paradigm for diabetes management.

Video content above is prompted by the following:

  • Tell us about the COORDINATE-Diabetes trial.
  • What were the objectives of COORDINATE-Diabetes and how was the trial designed?
  • What interventions were provided?
  • What were the results of the study?
  • What are future opportunities to improve CRM care based on this trial?

This activity is supported by Boehringer Ingelheim Pharmaceuticals Inc. and Eli Lilly and Company who provided financial support for this program.


Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
Screenshot of a webinar panel discussion with Viet Le, PA-C; Nathan Wong, PhD, MPH; Alison Bailey, MD; and Martha Gulati, MD, MS
World Hepatitis Day graphic | Image Credit: uazzal - stock.adobe.com
2 experts in this video
2 experts in this video
Dr Sundar Jagannath
1 expert in this video
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo